comparemela.com

Latest Breaking News On - Mantle cell lymphoma - Page 12 : comparemela.com

Dr Goy on Outcomes From An Expanded Access Study of Brexu-Cel in Relapsed/Refractory MCL

Andre Goy, MD, discusses outcomes with brexucabtagene autoleucel in patients with relapsed/refractory mantle cell lymphoma enrolled in the phase 2 ZUMA-2 trial and the expanded access ZUMA-18 study.

Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study

Dr Goy on the Influence of High-Risk Features on Treatment Decision-Making in MCL

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.